Physician profile
Rene Perez
NPI 1669687141
$19,936.96
in general payments reported to CMS, 2019-2025
22 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,707 · 2020: $5,949 · 2021: $1,364 · 2022: $5,520 · 2023: $2,970 · 2024: $1,049 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,625 · Food and Beverage: $1,773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,625.00 |
| Food and Beverage | $1,772.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $10,905.76 | 2019-2023 | Acessa Provu System |
| Meditrina | $3,658.80 | 2021-2023 | |
| Alliance Partners LLC | $1,913.83 | 2019 | |
| Abbvie INC. | $1,208.54 | 2019-2025 | |
| Intuitive Surgical, INC. | $562.49 | 2019-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $467.00 | 2024 | Truclear |
| Hologic Sales and Service, LLC | $330.97 | 2024-2025 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Organon LLC | $140.97 | 2021-2025 | Nexplanon |
| Acera Surgical, INC. | $134.28 | 2025 | Restrata Wound Matrix |
| Novo Nordisk INC | $124.99 | 2021 | |
| Myriad Genetic Laboratories, INC. | $121.89 | 2022 | |
| Coopersurgical, INC. | $117.11 | 2024-2025 | Ally II Ups, Paragard T 380a |
| Merck Sharp & Dohme LLC | $44.85 | 2019-2023 | Gardasil 9 |
| Shield Therapeutics INC | $43.80 | 2023-2025 | Accrufer |
| Pfizer INC. | $38.15 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $28.93 | 2021 | |
| Exeltis, USA INC. | $19.45 | 2021 | |
| Therapeuticsmd, INC. | $17.41 | 2019 | |
| Aspira Women'S Health INC | $16.98 | 2020 | |
| Minerva Surgical, INC | $15.15 | 2020 | |
| Melinta Therapeutics, LLC | $14.27 | 2019 | |
| Avion Pharmaceuticals | $11.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.